Bioavailability of Sublingual Peptides: An Honest Breakdown

Short answer: Bioavailability is the fraction of a dose that reaches your bloodstream in active form, and the sublingual route earns its reputation on that metric because it bypasses the gut and the liver's first pass. Human sublingual studies exist for supplement compounds [published human data], but no product-level measurement has been published for these strips.

What bioavailability actually means

Strip away the jargon and bioavailability is a simple idea: of the amount you take, what fraction reaches your bloodstream in a form that can act?

The reference point is an intravenous injection — 100% by definition. Every other route is measured against that. Swallow a compound and the gut and liver can dismantle much of it before it circulates (first-pass metabolism). Sublingual delivery dodges that gauntlet: the tissue under the tongue is thin, blood-rich, and drains toward general circulation without routing through the liver. We've laid out the anatomy in our sublingual delivery science explainer — this article picks up at the question everyone actually asks: okay, so how much?

The route's track record is genuinely strong

Before the numbers war, the wins. The sublingual route has decades of regulated drug products behind it — nitroglycerin under the tongue is the famous case, and it works precisely because this tissue absorbs. In supplement territory, the evidence is already on the board: a randomized crossover human trial found sublingual glutathione significantly raised plasma glutathione and the GSH/GSSG ratio, while the same dose swallowed orally produced no significant rise (Schmitt et al., 2015, PMC4536296) [published human data]. A 2022 clinical review of oral-mucosa glutathione delivery reached similar conclusions about the route's potential [published human data].

And the peptide-relevant frontier is moving: a company developing a sublingual NAD+ wafer reported a rat pharmacokinetic study showing peak blood NAD+ roughly doubling within 10 minutes of sublingual dosing, with claimed sublingual bioavailability around 22% versus IV [preclinical evidence], followed by a small company-sponsored human pilot reporting average blood NAD+ increases of +59% at two weeks [brand claim — unverified]. Early and industry-run — but exactly the kind of work that turns a plausible route into a measured one.

Reading the numbers you'll see online

Search this keyword and you'll find a numbers war: 9.7% here, 24% there, "up to 80–92%" on a reseller page. Each tier has a different provenance, and knowing it makes you immune to spin in both directions:

The "up to 80–92%" figure traces to InstaMed's own marketing materials [brand claim — unverified]. We can't find a peer-reviewed study behind it — so treat it as a company claim, not data.

The single-digit figures, like 9.7% typically trace to studies of orally swallowed peptides through the gut, where digestion destroys most of the dose. Applying them to a sublingual strip is a category error in the skeptical direction: the whole point of the mouth route is that part of the dose never goes through the gut.

The mid-range figures, like 24% or 70–75% generally trace to sublingual pharmacology literature for other drugs — mostly small molecules in engineered pharmaceutical formulations. They prove something real (the route performs) without proving anything automatic about a specific peptide film.

Notice the pattern: skeptics import numbers from a worse route, marketers import numbers from better molecules, and brands quote their own unverified figures. You're now ahead of all three.

Why molecule and formulation both matter

Bioavailability isn't a property of a route — it's a property of a specific molecule in a specific formulation.

The molecule half: size and charge govern what passively crosses mouth tissue. Small, uncharged compounds cross readily; large or charged ones lean more on formulation. Intact NAD+ (~663 Da, charged) is the harder case; BPC-157 (~1,419 Da) is large by mucosal standards but unusually gastric-stable, which gives its swallowed fraction documented oral/GI activity in animal models [preclinical evidence]. One number for "peptides" was never scientifically possible — the category spans a tenfold-plus size spectrum.

The formulation half: the film base, the excipients, dissolve speed, and dwell time all shift the absorbed fraction. The strips we carry use a pullulan film base with β-cyclodextrin and sunflower lecithin — ingredients with real delivery-science literature behind them. We describe them factually because they're on the label.

The honest context, once

Plainly, because you deserve the whole canvas: no published human pharmacokinetic study exists for these specific strip products, so no precise absorption percentage — high or low — can honestly be attached to them today. What exists is a medicine-proven route, human sublingual successes for comparable compounds, encouraging early peptide-adjacent data, and a well-understood path (a crossover PK study) by which these products will eventually get their own real numbers. We'd rather hand you that honest picture than a digit invented to close a sale.

How to shop smart without a number

If a product-level percentage doesn't exist yet, evaluate a strip on what you can verify:

• Label specificity. A real product states exactly what's in each strip — 100 mg NAD+, 500 mcg BPC-157 — not a "proprietary blend" total hiding the doses.
• Certificates of analysis. A good COA verifies identity and potency of the active — not just heavy metals and microbials.
• Excipient transparency. The full ingredient list should be printed and describable in plain language.

Our peptide safety and sourcing guide walks the full vetting framework. For label specificity in practice, compare any product page against our NAD+ sublingual strips or BPC-157 sublingual strips, where the active content per strip is stated outright.

The bottom line

Bioavailability is where the sublingual route's strengths are most concrete: a first-pass bypass with decades of medicine behind it, human wins already published for supplement-category compounds, and early peptide data pointing the right way. The product-specific numbers are still coming — and until they arrive, the smart shopper judges on what's verifiable. On that standard, a well-made strip is a format you can genuinely trust.

If you want the plain-English version first, start with whether peptides can absorb under the tongue; this page is the numbers version.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.